The early impact of gestational diabetes, hypertensive disorders of pregnancy, and obesity appears to grow as kids age.

Bernard Prendergast and Jordan Strom discuss the evolution of AS referral and how earlier treatment impacts patient outcomes.

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

The findings highlight the importance of rheumatology, cardiology, and primary care working together to intervene early.

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.

Individuals assigned male at birth who were pushed to change their identity had more inflammation and higher blood pressure.

The tool is less apt to overestimate ASCVD risk than the pooled cohort equations and in turn could reduce overtreatment.

With its twice-yearly dosing, the siRNA-based drug might lead to better compliance with treatment. Still, cost is an issue.

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).